EUVIMEDEUVIMED entdecken
Crossref

Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway

Shuai Wu, Ning Guo, Hanlin Xu, Yu Li, Tianyin Sun, Xiangfu Jiang, Dongdong Fu, Tingyu You, Shaoxi Diao, Yan Huang, Chengmu Hu

Biochemical Pharmacology · 2024-12 · 230 · 116594

DOI: 10.1016/j.bcp.2024.116594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024-12. Verfasst von Shuai Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical Univer…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Caveolin 1, NADPH Oxidase 4, Ferroptosis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Scientific Research Foundation of Education Department of Anhui Province of China, Anhui Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease globally, with a complex and contentious pathogenesis. Caveolin-1 (CAV1) is an important regulator of liver function and can mitigate liver injury by scavenging reactive oxygen species (ROS). Evidence suggests that NOX4 is a source of ROS production, that oxidative stress and ferroptosis are closely related, and that both are involved in the onset and progression of NAFLD. However, whether CAV1 attenuates liver injury in NAFLD caused by high-fat diet via the NOX4/ROS/GPX4 pathway remains unclear. An in vivo fatty liver model was established by feeding mice with a high-fat diet for 16 weeks. In addition, an in vitro fatty liver model was established by incubating AML-12 cells with free fatty acids for 24 h using an in vitro culture method. In our study, it was observed that a high-fat diet induces mitochondrial damage and worsens oxidative stress in NAFLD. This diet also hinders GPX4 expression, leading to an escalation of ferroptosis and lipid accumulation. To counteract these effects, intraperitoneal administration of CSD peptide in mice attenuated the high-fat diet-induced liver mitochondrial damage and ferroptosis. Likewise, overexpression of CAV1 resulted in an increase in GPX4 expression and a reduction in levels of ROS-mediated iron metamorphosis, thus mitigating the progression of the disease. However, the effects of CAV1 on GPX4-mediated ferroptosis and lipid deposition could be reversed by CAV1 small interfering RNA (SiRNA). Finally, NOX4 inhibitor (GLX351322) treatment increased CAV1 siRNA-mediated GPX4 expression and decreased the level of ROS-mediated ferroptosis. These findings suggest a potential mechanism underlying the protective role of CAV1 against high-fat diet-induced hepatotoxicity in NAFLD, shedding new light on the interplay between CAV1, GPX4, and ferroptosis in liver pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCaveolin 1NADPH Oxidase 4FerroptosisReactive Oxygen SpeciesPhospholipid Hydroperoxide Glutathione PeroxidaseMice, Inbred C57BLDiet, High-FatAnimalsMiceMaleSignal TransductionCell LineLiver

Stichwörter der Autor:innen

Caveolin-1FerroptosisLipid depositionNOX4/ROS/GPX4Non-alcoholic fatty liver diseaseOxidative stress

Substanzen

Caveolin 1NADPH Oxidase 4Reactive Oxygen SpeciesPhospholipid Hydroperoxide Glutathione PeroxidaseNox4 protein, mouseglutathione peroxidase 4, mouseCav1 protein, mouse

Autor:innen und Institutionen

  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medic…

Förderung

  • Scientific Research Foundation of Education Department of Anhui Province of China
  • Anhui Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Wu, S., Guo, N., Xu, H., Li, Y., Sun, T., Jiang, X., Fu, D., You, T., Diao, S., Huang, Y., & Hu, C. (2024). Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway. Biochemical Pharmacology, 230, 116594. https://doi.org/10.1016/j.bcp.2024.116594

Vancouver

Wu S, Guo N, Xu H, Li Y, Sun T, Jiang X, et al. Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway. Biochemical Pharmacology. 2024;230:116594. doi:10.1016/j.bcp.2024.116594

BibTeX
@article{Wu2024,
  author = {Wu, Shuai and Guo, Ning and Xu, Hanlin and Li, Yu and Sun, Tianyin and Jiang, Xiangfu and Fu, Dongdong and You, Tingyu and Diao, Shaoxi and Huang, Yan and Hu, Chengmu},
  title = {Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway},
  journal = {Biochemical Pharmacology},
  year = {2024},
  volume = {230},
  pages = {116594},
  doi = {10.1016/j.bcp.2024.116594}
}
Kostenlos starten →